GlassScriptPhysician profile
Manisha Bhutani
NPI 1679662464
$15,561.59
in general payments reported to CMS, 2019-2025
48 companies · $2,706 in 2025
The $2,706 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,711 · 2020: $1,558 · 2021: $2,198 · 2022: $748 · 2023: $1,138 · 2024: $1,503 · 2025: $2,706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,323 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,323.07 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tosoh Bioscience, INC. | $4,006.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $2,236.09 | 2019-2025 | Tezspire, Airsupra, Farxiga |
| Novo Nordisk INC | $1,986.12 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $1,247.79 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,046.49 | 2019-2025 | Jardiance, Spiriva Respimat, Synjardy |
| Lilly USA, LLC | $695.84 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $658.72 | 2019-2025 | Ubrelvy, Synthroid |
| Amgen INC. | $482.41 | 2019-2025 | Krystexxa, Evenity |
| Abbott Laboratories | $343.03 | 2021-2025 | Freestyle Libre 3, Freestyle Libre |
| Exact Sciences Corporation | $296.08 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $289.35 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $200.94 | 2021-2023 | |
| Axogen | $140.00 | 2021 | |
| Esperion Therapeutics, INC. | $125.00 | 2021 | |
| Jazz Pharmaceuticals INC. | $125.00 | 2021 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manisha Bhutani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.